AGFG2 Antikörper (AA 381-481)
Kurzübersicht für AGFG2 Antikörper (AA 381-481) (ABIN872890)
Target
Alle AGFG2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 381-481
-
Verwendungszweck
- AGFG2 Polyclonal Antibody
-
Homologie
- Human,Mouse,Rat,Cow,Sheep,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human AGFG2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:300-5000),
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- AGFG2 (ArfGAP with FG Repeats 2 (AGFG2))
-
Andere Bezeichnung
- AGFG2
-
Hintergrund
-
Synonyms: Agfg2, AGFG2_HUMAN, Arf GAP domain and FG repeats containing protein 2, Arf-GAP domain and FG repeats-containing protein 2, HIV-1 Rev-binding protein-like protein, HIV1 Rev binding protein like protein, HRBL, Nucleoporin, RAB-R, RABR, Rev/Rex activation domain-binding protein related.
Background: Required for vesicle docking or fusion during acrosome biogenesis (By similarity). May play a role in RNA trafficking or localization. In case of infection by HIV-1, acts as a cofactor for viral Rev and promotes movement of Rev-responsive element-containing RNAs from the nuclear periphery to the cytoplasm. This step is essential for HIV-1 replication.
Target
-